02838: Standardization of rLiNTPDase2 and Derived Chimeras as Antigens on Immunochromatographic Assay for Diagnosis of Canine Visceral Leishmaniasis
Grant Status: Open
Canine visceral leishmaniasis (CVL) corresponds to the most aggressive and lethal form of leishmaniasis manifesting in dogs. In North, Central and South America, CVL is caused by Leishmania infantum and diagnostic techniques currently used to identify infected animals have important limitations in sensitivity and specificity. The main goal of this study is to develop new and accessible technologies for CVL diagnosis based on more specific antigens. This accomplishment has high potential to create a positive impact on diagnostic strategies all over the globe and to increase the amount of correctly diagnosed and treated dogs.
None at this time.
- 00799-A: Development of Sensitive and Specific Diagnostic Tests to Aid in Eradication of Leishmania infantum from North American Foxhounds
- 01220-A: Determination of Leishmania infantum Infection Rates in U.S. Foxhounds and Neapolitan Mastiffs via Serology and qPCR and Survey of Risk Factors for Visceral Leishmaniasis
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.